作者
Yu Zhang,Ping Yu,Yingzhe Zhang,Kazunobu Sugihara,Xiaomin Zhu,Shouxin Zhang,Xiao Yang,Xiaoyan Li,Yacong Liu,Hengli Zhang,Xiaowei Yan,Hengkai Zhang,Fengbin Lin,Yunhe Song,Xinbo Gao,Huiping Yuan,Guangxian Tang,Wenzong Zhou,Sujie Fan,Guangfu Dang,Li Tang,Weirong Chen,Li Wang,Ki Ho Park,Keith Barton,Tin Aung,Dennis S.C. Lam,Robert N. Weinreb,Lin Xie,Masaki Tanito,Liuzhi Zeng,Xiulan Zhang
摘要
Purpose
To compare the efficacy and safety of 120-, 240-, and 360-degree goniotomy (GT) with or without phacoemulsification with intraocular lens implantation (PEI) for patients with primary open-angle glaucoma (POAG). Design
Multicenter, retrospective, comparative, nonrandomized interventional study. Methods
Patients diagnosed with POAG who underwent GT with or without PEI were included, and divided into 6 groups: 1) standalone 120-degree GT (120GT); 2) standalone 240-degree GT (240GT); 3) standalone 360-degree GT (360GT); 4) PEI + 120GT; 5) PEI + 240GT; and 6) PEI + 360GT. Data on intraocular pressure (IOP), the number of ocular hypotensive medications, and complications were collected and compared. Success was defined as a postoperative IOP within the range of 6 to 18 mm Hg and a 20% reduction from baseline without further glaucoma surgery. Complete success and qualified success were defined as the above without and with ocular hypotensive medications, respectively. Results
Three hundred eight eyes of 231 patients were included with a mean follow-up of 14.4 ± 8.6 months (6.0-48.0 months). There were no significant differences in the reductions in IOP and number of medications and cumulative survival probability for complete and qualified success rates among the 3 groups of standalone GT and PEI + GT. The 360GT group had the highest proportion of hyphema with or without PEI. Conclusions
120GT, 240GT, and 360GT with or without PEI showed similar efficacy in reducing IOP and medications used in POAG. 360GT with or without PEI was more likely to cause hyphema compared with 120GT or 240GT. 120GT with or without PEI was sufficient for treating POAG with or without cataract.